Translating patient related outcome measures into practice— lessons to be learnt
The landscape of type 2 diabetes (T2D) therapy is continuously evolving. Recent therapeutic trials showing cardiovascular and mortality benefit have influenced its management in clinical practice (1,2). It is increasingly apparent that T2D is a heterogeneous entity (3). Hence, there is a need to emphasize patient-centred approaches to care (3). In current clinical practice, metabolic and biochemical targets remain the predominant drivers for diabetes management. Patient related outcome measures (PROMs) have been a topic of research interest, but its additional value in routine clinical practice remains uncertain. This editorial explores the findings from the recently published PANORAMA study and its clinical implications (4).